Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Atomized Midazolam + Nitrous Oxide vs Nitrous Oxide Alone in Anxious Pediatric Dental Patients
NCT07876024Recruiting
- Sponsor
- Shaheed Zulfiqar Ali Bhutto Medical University
- Start
- Oct 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of midazolam in Dental anxiety, sponsored by Shaheed Zulfiqar Ali Bhutto Medical University. Primary endpoint: Treatment Success Rate at 45 months. Started Oct 2026; status: recruiting.
02
Drugs
midazolam
03
Conditions
Dental anxiety
Beyond the preview
Go deeper on NCT07876024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07876024.